This five-part series explores the factors that contribute to racial survival disparity in breast cancer and proposes interventions for change.... More »
The longer a woman’s reproductive years last, the less she may be prone to postmenopausal depression, a large meta-analysis has determined.
The ris... More »
Since cervical cancer is “a rather indolent disease,” more frequent testing is much more likely to result in anxiety and unnecessary treatment tha... More »
Ovarian suppression with triptorelin during chemotherapy for early-stage breast cancer significantly increased the chances that women would recover th... More »
SAN ANTONIO – The investigational oral tyrosine kinase inhibitor neratinib showed continued benefit in terms of reduced invasive disease-free survival at 3 years of follow-up in women with...
Women who become pregnant while in remission from Hodgkin lymphoma were not at increased risk for cancer relapse, according to an analysis of data from Swedish health care registries combined with...
SAN ANTONIO – Hospitalization for an infection within the first year following diagnosis of primary nonmetastatic breast cancer is a red flag for increased risk of subsequent development of distant...
SAN ANTONIO – Two large phase III randomized trials comparing anastrozole and tamoxifen for prevention of disease recurrence in postmenopausal women with ductal carcinoma in situ were presented at...
